Cetuximab dosing by rash is the scaling of EVEREST meaningful?
The small EVEREST trial has shown that the concept of guiding cetuximab dose escalation using the clinical parameter of acneiform skin rash is safe. However, as no significant increase of cetuximab efficacy could be observed, [more]